The True Cost of Substance Use Disorders in the United States

Substance use disorders cost the United States $442 billion annually — and that burden doesn’t fall in one place. It is absorbed across every sector of the healthcare and social services system, by the 48.5 million Americans living with a SUD, the providers treating them, the health plans covering them, the employers depending on them, and the public agencies that absorb the cost when treatment fails or never happens at all.

The cost of inaction is not zero — it is the highest-cost option, paid sector by sector, at the point of crisis rather than the point of intervention. Yet only 13% of those who need SUD treatment actually receive it, leaving the remaining 87% cycling through emergency departments, criminal justice systems, and social services at a far greater cost than treatment would have required.

This white paper examines that burden through four interconnected lenses — the behavioral health provider, the health plan, the employer, and the public sector — quantifying what untreated and undertreated SUD costs each stakeholder, and presenting the evidence base for why prevention, access to treatment, and sustained recovery engagement are not just clinical imperatives but sound financial strategy.